Name | fargesin |
---|---|
Synonyms |
Fargesin
1,3-Benzodioxole, 5-[(1S,3aR,4R,6aR)-4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]- 5-[(1S,3aR,4R,6aR)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole (+)-demethoxyaschantin methyl piperitol (+)-kobusin Methyl pluviatilol UNII:GR9853GI71 |
Description | Fargesin is a bioactive neolignan isolated from magnolia plants,with antihypertensive and anti-inflammatory effects[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | Fargesin exhibits anti-inflammation effects on THP-1 cells via suppression of PKC pathway including downstream JNK, nuclear factors AP-1 and NF-ĸB[3]. Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis[4]. |
In Vivo | Fargesin has antihypertensive effect in 2K1C hypertensive rats via inhibiting oxidative stress and promoting NO release[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 506.4±50.0 °C at 760 mmHg |
Melting Point | 132.0 to 136.0 °C |
Molecular Formula | C21H22O6 |
Molecular Weight | 370.396 |
Flash Point | 208.9±30.0 °C |
Exact Mass | 370.141632 |
PSA | 55.38000 |
LogP | 3.20 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.580 |